Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Selected Balance Sheet Data (Tables)

v3.7.0.1
Note 2 - Selected Balance Sheet Data (Tables)
 9 Months Ended
Mar. 31, 2017
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
 
 
March 31,
 
 
June 30,
 
 
 
2017
 
 
2016
 
Raw materials
   $
22,661
     $
22,963
  
Finished goods
    
41,106
      
34,139
  
Inventories, net
   $
63,767
     $
57,102
  
Property, Plant and Equipment [Table Text Block]
 
 
March 31,
 
 
June 30,
 
 
 
2017
 
 
2016
 
                 
Land
   $
6,270
     $
6,270
  
Buildings and improvements
    
157,515
      
157,963
  
Machinery and equipment
    
94,008
      
82,018
  
Property and equipment, cost
    
257,793
      
246,251
  
Accumulated depreciation and amortization
    
(125,647
)
    
(113,889
)
Property and equipment, net
   $
132,146
     $
132,362
  
Schedule of Intangible Assets and Goodwill [Table Text Block]
 
 
March 31,
 
 
June 30,
 
 
 
2017
 
 
2016
 
                 
Developed technology
   $
232,873
     $
120,611
  
Trade names
    
81,695
      
63,706
  
Customer relationships
    
272,752
      
191,118
  
Non-compete agreements
    
3,457
      
3,284
  
Intangible assets
    
590,777
      
378,719
  
Accumulated amortization
    
(108,084
)
    
(75,595
)
Net amortizable intangible asset
    
482,693
      
303,124
  
In process research and development
    
-
      
7,400
  
Intangible assets, net
   $
482,693
     $
310,524
  
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Beginning balance
   $
310,524
  
Acquisitions (Note 3)
    
208,869
  
Amortization expense
    
(33,504
)
Currency translation
    
(3,196
)
Ending balance
   $
482,693
  
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
2017
   $
11,651
  
2018
    
46,472
  
2019
    
45,726
  
2020
    
45,086
  
2021
    
44,741
  
2022
    
43,118
  
Thereafter
    
245,899
  
Total
   $
482,693
  
Schedule of Goodwill [Table Text Block]
 
 
Biotechnology
 
 
Diagnostics
 
 
Protein Platforms
 
 
Total
 
Beginning balance
   $
108,802
     $
103,270
     $
218,810
     $
430,882
  
Acquisitions (Note 3)
    
141,557
      
 
      
 
      
141,557
  
Prior year acquisitions (Note 3)
    
 
      
 
      
1,809
      
1,809
  
Currency translation
    
(2,633
)
    
 
      
(1,877
 )    
(4,510
)
Ending balance
   $
247,726
     $
103,270
     $
218,742
     $
569,738
  
Schedule of Other Assets, Noncurrent [Table Text Block]
 
 
March 31,
 
 
June 30,
 
 
 
2017
 
 
2016
 
Investments
   $
40,385
     $
385
  
Other
    
2,427
      
1,537
  
    $
42,812
     $
1,922